<DOC>
	<DOCNO>NCT00451815</DOCNO>
	<brief_summary>To assess preliminary safety tolerability multiple oral dos BIIB014 subject early PD .</brief_summary>
	<brief_title>BIIB014 Phase 2a Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>3- ( 4-amino-3-methylbenzyl ) -7- ( 2-furyl ) -3H- ( 1,2,3 ) triazolo ( 4,5-d ) pyrimidine-5-amine</mesh_term>
	<criteria>Unless otherwise specify , eligible participate study , candidate must meet following eligibility criterion time Baseline Visit ( Day –1 ) : 1 . Must give write informed consent . Must also provide authorization require local law . 2 . Aged 30 78 year old time inform consent . 3 . If female , must postmenopausal least 1 year , surgically sterile , willing practice effective contraception study . Nursing mother , pregnant woman , woman plan become pregnant study exclude . 4 . Carry diagnosis probable idiopathic PD , make Movement Disorder Specialist , asymmetric onset least 2 follow cardinal feature PD : bradykinesia , rigidity , classic PD rest tremor . 5 . Be Hoehn &amp; Yahr Stage IIII inclusive OFF . 6 . Have Total Unified PD Rating Scale ( UPDRS ) OFF score ³ 8 . 7 . Have take prescribed medication PD minimum 2 week Baseline Visit ( Day 1 ) . 8 . Are willing abstain alcohol duration study . 9 . Have clinically significant baseline ECG ( 12lead ) laboratory abnormality ( determined Investigator ) , unless exempt Biogen Idec Medical Director . 10 . Agree provide blood sample mRNA DNA analysis , collect bank may use exploratory pharmacogenomic study . Exclusion Criteria Unless otherwise specify , candidate exclude study entry follow exclusion criterion exist time Baseline Visit ( Day –1 ) : 1 . Mini Mental State Examination ( MMSE ) score &lt; 27 . 2 . History clinical feature impair downward gaze , prominent axial rigidity , gait initiation failure , autonomic dysfunction , etc . consistent atypical parkinsonism syndrome . 3 . Any significant nonPD central nervous system disorder . 4 . Significant AXIS I psychiatric disease define Diagnostic Statistical Manual Mental Disorders , 4th editionRevised ( DSM IVTR , American Psychiatric Association , 2000 ) . 5 . History surgical intervention PD ( pallidotomy , thalamotomy , deep brain stimulation , etc. ) . 6 . Participation previous adenosine A2A trial . 7 . Participation investigational drug study within 1 month prior randomization trial . 8 . History malignancy unless exemption grant Biogen Idec Medical Director . 9 . History severe allergic anaphylactic reaction drug . 10 . Clinically significant cardiac , renal , pulmonary , hematopoietic , endocrine , hepatic disease . 11 . Abnormal laboratory result follow : AST , ALT , total bilirubin , GGT level &gt; 1.5 x upper limit normal ; serum lipase &gt; upper limit normal ; WBC &lt; 4,000 cells/mm3 hemoglobin &lt; 10 , abnormal laboratory value could interfere assessment safety . 12 . Supine ( measure duplicate 10 minute rest ) standing ( measure duplicate 3 minute change supine stand position ) blood pressure &gt; 150 &lt; 90 mmHg systolic &gt; 90 &lt; 40 mmHg diastolic 2 consecutive occasion . 13 . Orthostatic hypotension define decrease systolic BP &gt; 20 mmHg diastolic blood pressure &gt; 10 mmHg measure duplicate 3 minute change supine stand position . 14 . History human immunodeficiency virus ( HIV ) . 15 . Positive hepatitis C antibody and/or positive hepatitis B surface antigen ( HBsAg ) screening . 16 . History drug alcohol abuse define DSM IVTR ( American Psychiatric Association , 2000 ) within 1 year prior randomization trial . 17 . Alcohol use within 72 hour Baseline Visit ( Day –1 ) . 18 . Donation blood plasma excess 500 mL within 3 month Screening Visit . 19 . Unwillingness inability comply requirement protocol include presence condition ( physical , mental , social ) likely affect subject ’ ability comply protocol . 20 . Any reason , opinion Investigator and/or Sponsor , subject determine unsuitable enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>